| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 15 |
| 1 | METHOTREXATE | 14 |
| 2 | LEFLUNOMIDE | 12 |
| 3 | PREDNISONE | 12 |
| 4 | CELECOXIB | 10 |
| 5 | MAGNESIUM | 10 |
| 6 | NAPROXEN | 10 |
| 7 | NAPROXEN SODIUM | 10 |
| 8 | RIZATRIPTAN | 10 |
| 9 | SULFASALAZINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORPHENADRINE CITRATE | 2 | 0.0032 |
| 1 | FROVATRIPTAN SUCCINATE | 1 | 0.0013 |
| 2 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 3 | NARATRIPTAN | 1 | 0.0007 |
| 4 | DESOXIMETASONE | 9 | 0.0005 |
| 5 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 6 | FRUQUINTINIB | 1 | 0.0003 |
| 7 | QUININE | 2 | 0.0002 |
| 8 | INDAPAMIDE | 4 | 0.0002 |
| 9 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 17 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 3 | Antirheumatic Agent [EPC] | 12 |
| 4 | Aminosalicylate [EPC] | 10 |
| 5 | Kinase Inhibitor [EPC] | 8 |
| 6 | Proton Pump Inhibitor [EPC] | 5 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 4 |
| 8 | Azole Antifungal [EPC] | 4 |
| 9 | Thiazide-like Diuretic [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 12 | 0.0001 |
| 1 | Aminosalicylate [EPC] | 10 | 0.0001 |
| 2 | Thiazide-like Diuretic [EPC] | 4 | 0.0001 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 9 | Phenothiazine [EPC] | 1 | 0.0000 |